^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Small Intestinal Carcinoma
    Regimen:FOLFOX
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    ...FOLFOX or CAPEOX are recommended as first-line therapy options for treatment of patients with advanced SBA who are appropriate for intensive therapy.